Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Carboplatin/administration & dosage/*therapeutic use"'
Autor:
Fountzilas, George, Dimopoulos, M. A., Papadimitriou, C., Kalogera-Fountzila, Anna, Aravantinos, Gerasimos, Bafaloukos, Dimitrios, Athanasiades, A., Nikolaides, C., Keramopoulos, A., Pavlidis, Nicholas, Kosmidis, Paraskevas A., Skarlos, Dimosthenis V.
Publikováno v:
Annals of Oncology
Summary Purpose To evaluate the activity and toxicity of the combination of paclitaxel given by three-hour infusion, and carboplatin as first-line chemotherapy in patients with advanced breast cancer (ABC). Background Paclitaxel is an active agent in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96428ecd08c0035ccd4b59c1e9f340dd
https://doi.org/10.1023/a:1008466928323
https://doi.org/10.1023/a:1008466928323
Autor:
Dimosthenis Skarlos, E. Efstathiou, H. P. Kalofonos, Dimitrios Farmakis, George Fountzilas, Evangelos Briasoulis, Emmanouel Salamalekis, Meletios A. Dimopoulos, Gerasimos Aravantinos, Theofanis Economopoulos, Dimitrios Pectasides
Publikováno v:
Gynecologic oncology. 97(2)
Purpose. Ovarian clear-cell carcinomas (OCCC) are known to be possibly resistant to platinum-based chemotherapy and to have a poorer prognosis with respect to other subtypes of epithelial ovarian cancer (EOC). This study was undertaken to compare res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d2557135068efd2406ce6e47fbced1d
https://pubmed.ncbi.nlm.nih.gov/16125757
https://pubmed.ncbi.nlm.nih.gov/16125757